Literature DB >> 29218518

Evaluating the Efficacy of GLUT Inhibitors Using a Seahorse Extracellular Flux Analyzer.

Changyong Wei1, Monique Heitmeier2, Paul W Hruz2, Mala Shanmugam3.   

Abstract

Glucose is metabolized through anaerobic glycolysis and aerobic oxidative phosphorylation (OXPHOS). Perturbing glucose uptake and its subsequent metabolism can alter both glycolytic and OXPHOS pathways and consequently lactate and/or oxygen consumption. Production and secretion of lactate, as a consequence of glycolysis, leads to acidification of the extracellular medium. Molecular oxygen is the final electron acceptor in the electron transport chain, facilitating oxidative phosphorylation of ADP to ATP. The alterations in extracellular acidification and/or oxygen consumption can thus be used as indirect readouts of glucose metabolism and assessing the impact of inhibiting glucose transport through specific glucose transporters (GLUTs). The Seahorse bioenergetics analyzer can measure both the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR). The proposed methodology affords a robust, high-throughput method to screen for GLUT inhibition in cells engineered to express specific GLUTs, providing live cell read-outs upon GLUT inhibition.

Entities:  

Keywords:  ECAR; GLUT inhibitor; Glycolysis; Oxidative phosphorylation; Seahorse XF analyzer

Mesh:

Substances:

Year:  2018        PMID: 29218518     DOI: 10.1007/978-1-4939-7507-5_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity.

Authors:  Christopher Ronald Funk; Shuhua Wang; Kevin Z Chen; Alexandra Waller; Aditi Sharma; Claudia L Edgar; Vikas A Gupta; Shanmuganathan Chandrakasan; Jaquelyn T Zoine; Andrew Fedanov; Sunil S Raikar; Jean L Koff; Christopher R Flowers; Silvia Coma; Jonathan A Pachter; Sruthi Ravindranathan; H Trent Spencer; Mala Shanmugam; Edmund K Waller
Journal:  Blood       Date:  2022-01-27       Impact factor: 25.476

2.  Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1.

Authors:  Maia Kavanagh Williamson; Naomi Coombes; Florian Juszczak; Marios Athanasopoulos; Mariam B Khan; Thomas R Eykyn; Ushani Srenathan; Leonie S Taams; Julianna Dias Zeidler; Andrea T Da Poian; Hendrik Huthoff
Journal:  Viruses       Date:  2018-03-07       Impact factor: 5.048

3.  Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion.

Authors:  R Commander; C Wei; A Sharma; J K Mouw; L J Burton; E Summerbell; D Mahboubi; R J Peterson; J Konen; W Zhou; Y Du; H Fu; M Shanmugam; A I Marcus
Journal:  Nat Commun       Date:  2020-03-24       Impact factor: 14.919

4.  MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells.

Authors:  Wenjun Liang; Ruichen Gao; Mingxia Yang; Xiaohua Wang; Kewei Cheng; Xuejun Shi; Chen He; Yemei Li; Yuying Wu; Lei Shi; Jingtao Chen; Xiaowei Yu
Journal:  Oncol Lett       Date:  2020-01-17       Impact factor: 2.967

5.  Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma.

Authors:  Richa Bajpai; Aditi Sharma; Abhinav Achreja; Claudia L Edgar; Changyong Wei; Arusha A Siddiqa; Vikas A Gupta; Shannon M Matulis; Samuel K McBrayer; Anjali Mittal; Manali Rupji; Benjamin G Barwick; Sagar Lonial; Ajay K Nooka; Lawrence H Boise; Deepak Nagrath; Mala Shanmugam
Journal:  Nat Commun       Date:  2020-03-06       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.